Oral Nutritional Supplements in Older Outpatients with Heart Failure: Rationale and Design of the ALIMENT-HF Trial
ESC Heart Failure · 2024
DOI: 10.1002/ehf2.14800 ↗At a glance
Journal article in ESC Heart Failure, 2024. Written by Yudai Fujimoto and 14 co-authors. Institution: Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. Major MEDLINE topics: Dietary Supplements, Heart Failure, Outpatients. Cited 1 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC 4.0).
Topics: Herzinsuffizienz
Abstract (original language)
Aims
The ALIMENT-HF trial aims to determine whether high-calorie and high-protein oral nutritional supplements (ONS) are safe and beneficial for older adult outpatients with heart failure (HF). Methods and results This multicentre, single-arm, interventional pilot trial is designed to evaluate the tolerance, efficacy, and safety of ONS in older adult outpatients with chronic HF, malnutrition, and anorexia. In total, 80 outpatients with HF regardless of their left ventricular ejection fraction will be treated with ONS, including high-energy (900 kcal/day) and high protein (36 g/day) supplementation, at eight sites in Japan. Inclusion criteria are as follows: age, ≥65 years; outpatients receiving maximally tolerated guideline-directed medical therapy for HF and without change in their diuretic dosage during the last 3 months; outpatients at risk of malnutrition, defined as a Malnutrition Universal Screening Tool score ≥1 point, and anorexia, defined using a Simplified Nutritional Appetite Questionnaire for the Japanese Elderly (SNAQ-JE) score of ≤14 points. Nutritional intervention will continue for up to 120 days, with an observational period lasting for a further 60 days. The primary outcome is a change in body weight between baseline and day 120.
Conclusions
The ALIMENT-HF trial will evaluate the tolerance, efficacy, and safety of high-calorie and high-protein-rich ONS in older outpatients with HF co-morbid with malnutrition and anorexia and will provide insightful information for future randomized controlled trials.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
- Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
- Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.
- Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Centre, Suita, Japan.
- Department of Cardiovascular Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
ORCID profiles: Yuya Matsue
Cite
APA
Fujimoto, Y., Dotare, T., Maekawa, E., Kamiya, K., Kitai, T., Kuwahara, K., Sugano, T., Konishi, M., Ohtani, T., Sakamoto, Y., Jujo, K., Noda, C., Ako, J., Yanagisawa, N., & Matsue, Y. (2024). Oral Nutritional Supplements in Older Outpatients with Heart Failure: Rationale and Design of the ALIMENT-HF Trial. ESC Heart Failure. https://doi.org/10.1002/ehf2.14800
Vancouver
Fujimoto Y, Dotare T, Maekawa E, Kamiya K, Kitai T, Kuwahara K, et al. Oral Nutritional Supplements in Older Outpatients with Heart Failure: Rationale and Design of the ALIMENT-HF Trial. ESC Heart Failure. 2024. doi:10.1002/ehf2.14800
BibTeX
@article{Fujimoto2024,
author = {Fujimoto, Yudai and Dotare, Taishi and Maekawa, Emi and Kamiya, Kentaro and Kitai, Takeshi and Kuwahara, Koichiro and Sugano, Teruyasu and Konishi, Masaaki and Ohtani, Tomohito and Sakamoto, Yoko and Jujo, Kentaro and Noda, Chiharu and Ako, Junya and Yanagisawa, Naotake and Matsue, Yuya},
title = {Oral Nutritional Supplements in Older Outpatients with Heart Failure: Rationale and Design of the ALIMENT-HF Trial},
journal = {ESC Heart Failure},
year = {2024},
doi = {10.1002/ehf2.14800}
}
EUVIMED